- Wegovy-maker Novo Nordisk builds case to win back investors Reuters
- Novo Aims to Beat Lilly With Something for Everyone in Obesity Bloomberg.com
- EASD 2025: REDEFINE 2 trial unveils meaningful weight reduction with CagriSema Yahoo Finance
- Novo Nordisk shares rise 5% on upbeat reaction to diabetes conference MarketScreener
- Novo Nordisk jump after positive investor reaction at medical conference in Vienna TradingView